Provided by Tiger Trade Technology Pte. Ltd.

CARGO Therapeutics

4.47
0.0000
Volume:- -
Turnover:48.92M
Market Cap:216.19M
PE:-0.97
High:4.47
Open:4.47
Low:4.47
Close:4.47
52wk High:25.45
52wk Low:3.00
Shares:48.36M
Float Shares:27.00M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.6318
EPS(LYR):-3.7248
ROE:-65.83%
ROA:-25.91%
PB:0.91
PE(LYR):-1.20

Loading ...

Company Profile

Company Name:
CARGO Therapeutics
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
CARGO Therapeutics, Inc., a clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients. The company's lead program is CRG-022, an autologous CD22 CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in B-cell malignancies. It also develops CRG-023, a tri-specific CAR T product candidate that targets tumor cells with three B-cell antigen targets. The company was formerly known as Syncopation Life Sciences, Inc. and changed its name to CARGO Therapeutics, Inc. in September 2022. CARGO Therapeutics, Inc. was incorporated in 2019 and is headquartered in San Mateo, California.